PCSK1N and Parkinson disease: Despite showing excellent predictive value in identifying PD cases (97.1% concordant sensitivity) in a larger patient cohort (BioFIND), both the Fmax and T50 of SAAs (RT-QuIC or PMCA) failed to correlate with any clinical parameter [27].